Venkatesh, Divya

Publications

Sort by

Co-Author Network

Paving the Way for Cancer Therapy a Nano Step at a Time. The Journal of pharmacology and experimental therapeutics. 2023 Academic Article GET IT
Times cited: 1
GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma. Cancer research. 2022 Academic Article GET IT
Times cited: 145
Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade. The Journal of clinical investigation. 2022 Academic Article GET IT
Times cited: 20
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine. Science translational medicine. 2022 Academic Article GET IT
Times cited: 24
p53 Frameshift Mutations Couple Loss-of-Function with Unique Neomorphic Activities. Molecular cancer research : MCR. 2021 Academic Article GET IT
Times cited: 11
The roles and regulation of MDM2 and MDMX: it is not just about p53. Genes & development. 2021 Information Resource GET IT
Times cited: 115
p21 can be a barrier to ferroptosis independent of p53. Aging. 2020 Academic Article GET IT
Times cited: 54
MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling. Genes & development. 2020 Academic Article GET IT
Times cited: 250

Sort by

Co-investigator Network

Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy awarded by National Cancer Institute Key Personnel 2022 - 2026